oddb2xml 3.0.5 → 3.0.6

checksums.yaml

@@ -1,7 +1,7 @@
 ---
 SHA256:
-  metadata.gz: ad986fc08f7abf1826b696378727e91dcb94cc53d5cdcdc2e0d009b755b92410
-  data.tar.gz: 7df4f478dc0cb3cfbd2dfcb796b87ad047aadfdbc37bc9eab80a58b9943078b1
+  metadata.gz: 8b3a91c4a9ff36983011294c705fd882a5cf2a7f60f972cd1e2de61877e353db
+  data.tar.gz: 7eb411ee5192d1a1eec417536e62761c5cbb833a075221ae283f1de577f5a4f6
 SHA512:
-  metadata.gz: 9b7a3266179a31992706cd2d3c999cc73b94cacf293617935475d801c1cc00ed5d23ed91daec53cf2c4f4a234d7057dfe82390980465f9b5e7a19bbff6bcca6c
-  data.tar.gz: d223b395fa978c6361c3f6c76ab2111558b029f97e9fad09b2c53d379f24f42f46c9b667da531c7505bcf7c121b5bd21cdd588ec64b530e80c718654c605a27f
+  metadata.gz: 92721b900cb1f754d87463c8a22fd552eabceee1ec12e16aca202084bfd18fa03f4def7ea3c2232ba4598d225c49f165a9c49cf995aae54f9a655d8551cb7267
+  data.tar.gz: ef7383d72a3535996c70d9d723b12649b09927cff97b9575e49f15553c87c92d142c940eded2fd22d4ef8399bf6f7d2538c72e413623485150837bfa43d0faf1

data/Gemfile.lock

@@ -1,7 +1,8 @@
 PATH
   remote: .
   specs:
-    oddb2xml (3.0.4)
+    oddb2xml (3.0.6)
+      csv
       htmlentities
       httpi
       mechanize (>= 2.8.5)
@@ -43,6 +44,7 @@ GEM
     crack (1.0.1)
       bigdecimal
       rexml
+    csv (3.3.5)
     diff-lcs (1.6.2)
     domain_name (0.6.20240107)
     flexmock (3.0.2)

data/History.txt

@@ -1,3 +1,10 @@
+=== 3.0.6 / 06.05.2026
+* FHIR: extract Indikationscode (XXXXX.NN) from ClinicalUseDefinition resources by combining FOPHDossierNumber with each CUD's .NN id-suffix; expose as item[:indication_codes] (and per package) so downstream builders can include it on prescriptions and invoices as required by BAG from 2026-07-01 (issue #113)
+* Declare csv as a runtime dependency in the gemspec (csv was removed from Ruby's default gems in 3.4)
+
+=== 3.0.5 / 25.04.2026
+* Refdata cleanup: compensate the doubled-dose template bug in Refdata.Articles.xml (e.g. "30 mg / 30 mg / 100 Tablette") by collapsing to a single token. Guarded by a Swissmedic-side comma check so real combination products are untouched (issue #112)
+
 === 3.0.4 / 24.04.2026
 * Firstbase: switch -b/--firstbase from the deprecated pillbox.oddb.org XLSX to the GS1 Switzerland CSV at https://id.gs1.ch/01/07612345000961 (full firstbase barcode registry, ~189k items). Downloaded file is now firstbase.csv; FirstbaseExtractor now parses CSV with headers instead of XLSX.
 

data/lib/oddb2xml/fhir_support.rb

@@ -159,7 +159,7 @@ module Oddb2xml
   module FHIR
     # Bundle represents one line in the NDJSON file
     class Bundle
-      attr_reader :medicinal_product, :packages, :authorizations, :ingredients
+      attr_reader :medicinal_product, :packages, :authorizations, :ingredients, :clinical_use_definitions
 
       def initialize(json_line)
         data = JSON.parse(json_line)
@@ -174,6 +174,7 @@ module Oddb2xml
         @packages = []
         @authorizations = []
         @ingredients = []
+        @clinical_use_definitions = []
 
         @entries.each do |entry|
           resource = entry["resource"]
@@ -186,11 +187,32 @@ module Oddb2xml
             @authorizations << Authorization.new(resource)
           when "Ingredient"
             @ingredients << Ingredient.new(resource)
+          when "ClinicalUseDefinition"
+            @clinical_use_definitions << ClinicalUseDefinition.new(resource)
           end
         end
       end
     end
 
+    # ClinicalUseDefinition carries one indication. Its `id` ends in ".NN",
+    # the per-indication suffix that combines with the FOPHDossierNumber
+    # (XXXXX) on the reimbursement RegulatedAuthorization to form the
+    # Indikationscode XXXXX.NN required by BAG from 2026-07-01.
+    class ClinicalUseDefinition
+      attr_reader :id, :nn_suffix, :type, :text
+
+      def initialize(resource)
+        @id = resource["id"]
+        @type = resource["type"]
+        @nn_suffix = @id&.[](/\.(\d{2})\z/, 1)
+        @text = resource.dig("indication", "diseaseSymptomProcedure", "concept", "text")
+      end
+
+      def indication?
+        @type == "indication"
+      end
+    end
+
     class MedicinalProduct
       attr_reader :names, :atc_code, :classification, :it_codes
 
@@ -427,6 +449,11 @@ module Oddb2xml
         prep.OrgGenCode = map_org_gen_code(mp.classification)
         prep.ItCode = mp.it_code  # Add IT code
 
+        # Indikationscodes (BAG: XXXXX.NN, mandatory on prescriptions/invoices
+        # from 2026-07-01). Build from FOPHDossierNumber (reimbursement auth)
+        # plus each ClinicalUseDefinition's .NN suffix. See issue #113.
+        prep.IndicationCodes = build_indication_codes(bundle)
+
         # Map packages
         prep.Packs = OpenStruct.new
         prep.Packs.Pack = bundle.packages.map do |pkg|
@@ -535,6 +562,21 @@ module Oddb2xml
         reimbursement&.cost_share
       end
 
+      def build_indication_codes(bundle)
+        reimbursement = bundle.authorizations.find(&:reimbursement_sl?)
+        dossier = reimbursement&.foph_dossier_no
+        return [] unless dossier && !bundle.clinical_use_definitions.empty?
+
+        bundle.clinical_use_definitions.each_with_object([]) do |cud, acc|
+          next unless cud.indication? && cud.nn_suffix
+          acc << OpenStruct.new(
+            code: "#{dossier}.#{cud.nn_suffix}",
+            cud_id: cud.id,
+            text: cud.text
+          )
+        end
+      end
+
       def map_org_gen_code(classification)
         return nil unless classification
 
@@ -616,6 +658,13 @@ module Oddb2xml
         item[:comment_it] = ""
         item[:it_code] = (itc = seq.ItCode) ? itc : ""  # NOW available in FHIR!
 
+        # Indikationscodes (BAG XXXXX.NN, see issue #113). Each entry is a
+        # Hash with :code, :cud_id, :text — mandatory on rx/invoices from
+        # 2026-07-01.
+        item[:indication_codes] = Array(seq.IndicationCodes).map do |ic|
+          {code: ic.code, cud_id: ic.cud_id, text: ic.text}
+        end
+
         # Build substances array
         item[:substances] = []
         if seq.Substances && seq.Substances.Substance
@@ -673,7 +722,8 @@ module Oddb2xml
               sl_entry: true,
               swissmedic_category: (cat = pac.SwissmedicCategory) ? cat : "",
               swissmedic_number8: (num = pac.SwissmedicNo8) ? num : "",
-              prices: {exf_price: exf, pub_price: pub}
+              prices: {exf_price: exf, pub_price: pub},
+              indication_codes: item[:indication_codes]
             }
 
             # Map limitations from FHIR

data/lib/oddb2xml/version.rb

@@ -1,3 +1,3 @@
 module Oddb2xml
-  VERSION = "3.0.5"
+  VERSION = "3.0.6"
 end

data/oddb2xml.gemspec

@@ -38,6 +38,7 @@ Gem::Specification.new do |spec|
   spec.add_dependency "htmlentities"
   spec.add_dependency "webrick", ">= 1.8.2"
   spec.add_dependency "rexml", ">= 3.3.9"
+  spec.add_dependency "csv"  # bundled with Ruby <= 3.3, gem from 3.4 onwards
   spec.add_dependency "standardrb"
   spec.add_dependency "rack", ">= 3.1.20"
 

data/spec/data/fhir/cyramza.ndjson

@@ -0,0 +1 @@
+{"resourceType":"Bundle","id":"9a91dc6e-3410-4020-9375-b2cae207e1bf","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-bundle"]},"type":"collection","entry":[{"fullUrl":"http://fhir.epl.bag.admin.ch/MedicinalProductDefinition/de872be1-02ff-4b8e-8691-658099182eb7","resource":{"resourceType":"MedicinalProductDefinition","id":"de872be1-02ff-4b8e-8691-658099182eb7","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Cyramza Inf Konz 100 mg/10 ml</div>"},"classification":[{"coding":[{"system":"http://www.whocc.no/atc","code":"L01FG02","display":"Ramucirumab"}]},{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus","code":"070000","display":"07. STOFFWECHSEL"}]},{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus","code":"071600","display":"07.16. Oncologica"}]},{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus","code":"071610","display":"07.16.10. Cytostatica"}]}],"name":[{"productName":"Cyramza Inf Konz 100 mg/10 ml","usage":[{"country":{"coding":[{"system":"urn:iso:std:iso:3166","code":"CH","display":"Switzerland"}]},"language":{"coding":[{"system":"urn:ietf:bcp:47","code":"de-CH","display":"German (Switzerland)"}]}}]},{"productName":"Cyramza conc perf 100 mg/10 ml","usage":[{"country":{"coding":[{"system":"urn:iso:std:iso:3166","code":"CH","display":"Switzerland"}]},"language":{"coding":[{"system":"urn:ietf:bcp:47","code":"fr-CH","display":"French (Switzerland)"}]}}]},{"productName":"Cyramza Inf Konz 100 mg/10 ml","usage":[{"country":{"coding":[{"system":"urn:iso:std:iso:3166","code":"CH","display":"Switzerland"}]},"language":{"coding":[{"system":"urn:ietf:bcp:47","code":"it-CH","display":"Italian (Switzerland)"}]}}]}]}},{"fullUrl":"http://fhir.epl.bag.admin.ch/RegulatedAuthorization/65206","resource":{"resourceType":"RegulatedAuthorization","id":"65206","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Marketing Authorisation 65206 for MedicinalProductDefinition de872be1-02ff-4b8e-8691-658099182eb7</div>"},"contained":[{"resourceType":"Organization","id":"7601001261853","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"]},"identifier":[{"system":"urn:oid:2.51.1.3","value":"7601001261853"}],"name":"Eli Lilly (Suisse) SA"}],"identifier":[{"system":"http://fhir.ch/ig/ch-epl/sid/authno","value":"65206"}],"subject":[{"reference":"CHIDMPMedicinalProductDefinition/de872be1-02ff-4b8e-8691-658099182eb7"}],"type":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type","code":"756000002001","display":"Marketing Authorisation"}]},"region":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"CH","display":"Switzerland"}]}],"holder":{"reference":"#7601001261853"}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/PackagedProductDefinition/c3a247c9-d686-49ab-9344-892d8b93f148","resource":{"resourceType":"PackagedProductDefinition","id":"c3a247c9-d686-49ab-9344-892d8b93f148","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-packagedproductdefinition"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Cyramza Inf Konz 100 mg/10 ml Durchstf 1 Stk</div>"},"packageFor":[{"reference":"CHIDMPMedicinalProductDefinition/de872be1-02ff-4b8e-8691-658099182eb7"}],"containedItemQuantity":[{"unit":"Durchstf 1 Stk"}],"description":"Cyramza Inf Konz 100 mg/10 ml Durchstf 1 Stk","legalStatusOfSupply":[{"code":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply","code":"756005022001","display":"Medicinal product subject to medical or veterinary prescription single dispensation (A)"}]}}],"packaging":{"identifier":[{"system":"urn:oid:2.51.1.1","value":"7680652060015"}]}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/RegulatedAuthorization/65206001-c3a247c9-d686-49ab-9344-892d8b93f148","resource":{"resourceType":"RegulatedAuthorization","id":"65206001-c3a247c9-d686-49ab-9344-892d8b93f148","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Marketing Authorisation 65206001-c3a247c9-d686-49ab-9344-892d8b93f148 for PackagedProductDefinition c3a247c9-d686-49ab-9344-892d8b93f148</div>"},"contained":[{"resourceType":"Organization","id":"7601001261853","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"]},"identifier":[{"system":"urn:oid:2.51.1.3","value":"7601001261853"}],"name":"Eli Lilly (Suisse) SA"}],"identifier":[{"system":"http://fhir.ch/ig/ch-epl/sid/authno","value":"65206001"}],"subject":[{"reference":"CHIDMPPackagedProductDefinition/c3a247c9-d686-49ab-9344-892d8b93f148"}],"type":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type","code":"756000002001","display":"Marketing Authorisation"}]},"region":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"CH","display":"Switzerland"}]}],"holder":{"reference":"#7601001261853"}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/RegulatedAuthorization/9c50920a-2d9d-476f-89d8-9477c8840de9","resource":{"resourceType":"RegulatedAuthorization","id":"9c50920a-2d9d-476f-89d8-9477c8840de9","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Reimbursement SL 9c50920a-2d9d-476f-89d8-9477c8840de9 for PackagedProductDefinition c3a247c9-d686-49ab-9344-892d8b93f148</div>"},"contained":[{"resourceType":"Organization","id":"7601001261853","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"]},"identifier":[{"system":"urn:oid:2.51.1.3","value":"7601001261853"}],"name":"Eli Lilly (Suisse) SA"}],"extension":[{"url":"http://fhir.ch/ig/ch-epl/StructureDefinition/reimbursementSL","extension":[{"url":"FOPHDossierNumber","valueIdentifier":{"system":"urn:oid:2.16.756.1","value":"20403"}},{"url":"status","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status","code":"756001021001","display":"Reimbursed"}]}},{"url":"statusDate","valueDate":"2019-06-01"},{"url":"listingStatus","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status","code":"756001002001","display":"Listed"}]}},{"url":"listingPeriod","valuePeriod":{"start":"2019-06-01"}},{"url":"firstListingDate","valueDate":"2016-03-01"},{"url":"costShare","valueInteger":10},{"url":"priceModel","valueBoolean":true},{"url":"http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice","extension":[{"url":"type","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type","code":"756002005001","display":"Retail price"}]}},{"url":"changeType","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change","code":"756002006009","display":"Normal price mutation"}]}},{"url":"value","valueMoney":{"value":421.65,"currency":"CHF"}},{"url":"changeDate","valueDate":"2024-10-01"}]},{"url":"http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice","extension":[{"url":"type","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type","code":"756002005002","display":"Ex-factory price"}]}},{"url":"changeType","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change","code":"756002006009","display":"Normal price mutation"}]}},{"url":"value","valueMoney":{"value":372.61,"currency":"CHF"}},{"url":"changeDate","valueDate":"2024-10-01"}]}]}],"subject":[{"reference":"CHIDMPPackagedProductDefinition/c3a247c9-d686-49ab-9344-892d8b93f148"}],"type":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type","code":"756000002003","display":"Reimbursement SL"}]},"indication":[{"extension":[{"url":"http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation","extension":[{"url":"status","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus","code":"756002071001","display":"Limitation Reimbursed"}]}},{"url":"statusDate","valueDate":"2024-10-01"},{"url":"period","valuePeriod":{"start":"2024-10-01"}},{"url":"firstLimitationDate","valueDate":"2016-03-01"},{"url":"indicationCode","valueString":"20403.01"},{"url":"limitationIndication","valueReference":{"reference":"ClinicalUseDefinition/CYRAMZA.01"}}]}]},{"extension":[{"url":"http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation","extension":[{"url":"status","valueCodeableConcept":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus","code":"756002071001","display":"Limitation Reimbursed"}]}},{"url":"statusDate","valueDate":"2024-10-01"},{"url":"period","valuePeriod":{"start":"2024-10-01","end":"2027-09-30"}},{"url":"reimbursementEndDate","valueDate":"2027-12-31"},{"url":"firstLimitationDate","valueDate":"2016-03-01"},{"url":"indicationCode","valueString":"20403.02"},{"url":"limitationIndication","valueReference":{"reference":"ClinicalUseDefinition/CYRAMZA.02"}}]}]}],"holder":{"reference":"#7601001261853"}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/Ingredient/a5edbabc-f9d6-4019-ac6f-2a80fe033339","resource":{"resourceType":"Ingredient","id":"a5edbabc-f9d6-4019-ac6f-2a80fe033339","meta":{"profile":["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">Ramucirumabum 100 mg</div>"},"status":"draft","for":[{"reference":"CHIDMPMedicinalProductDefinition/de872be1-02ff-4b8e-8691-658099182eb7"}],"role":{"coding":[{"system":"http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role","code":"756005051001","display":"Active"}]},"substance":{"code":{"concept":{"text":"Ramucirumabum"}},"strength":[{"presentationQuantity":{"value":100,"unit":"mg"}}]}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/ClinicalUseDefinition/CYRAMZA.01","resource":{"resourceType":"ClinicalUseDefinition","id":"CYRAMZA.01","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">In Kombination mit Paclitaxel für die Behandlung von erwachsenen Patienten mit ECOG-Status 0 oder 1 mit fortgeschrittenem Adenokarzinom des Magens oder gastroösophagealen Übergangs mit einem Progress nach vorausgegangener Platin- und Fluoropyrimidin-haltiger Chemotherapie.\nAls Monotherapie für die Behandlung von erwachsenen Patienten mit ECOG-Status 0 oder 1 mit fortgeschrittenem Adenokarzinom des Magens oder des gastroösophagealen Übergangs mit einem Progress nach vorausgegangener Platin- oder Fluoropyrimidin-haltiger Chemotherapie, wenn diese Patienten für eine Kombinationstherapie mit Paclitaxel nicht geeignet sind.\nDie Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 20403.01</div>"},"type":"indication","indication":{"diseaseSymptomProcedure":{"concept":{"text":"In Kombination mit Paclitaxel für die Behandlung von erwachsenen Patienten mit ECOG-Status 0 oder 1 mit fortgeschrittenem Adenokarzinom des Magens oder gastroösophagealen Übergangs mit einem Progress nach vorausgegangener Platin- und Fluoropyrimidin-haltiger Chemotherapie.\nAls Monotherapie für die Behandlung von erwachsenen Patienten mit ECOG-Status 0 oder 1 mit fortgeschrittenem Adenokarzinom des Magens oder des gastroösophagealen Übergangs mit einem Progress nach vorausgegangener Platin- oder Fluoropyrimidin-haltiger Chemotherapie, wenn diese Patienten für eine Kombinationstherapie mit Paclitaxel nicht geeignet sind.\nDie Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 20403.01"}}}}},{"fullUrl":"http://fhir.epl.bag.admin.ch/ClinicalUseDefinition/CYRAMZA.02","resource":{"resourceType":"ClinicalUseDefinition","id":"CYRAMZA.02","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">In Kombination mit FOLFIRI (Irinotecan, Folsäure und 5-Fluorouracil) zur Behandlung von erwachsenen Patienten mit metastasiertem kolorektalem Karzinom (mKRK) mit Progress während oder nach vorausgegangener Therapie mit Bevacizumab, Oxaliplatin und einem Fluoropyrimidin. Die Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.\nDie Eli Lilly (Suisse) SA vergütet dem Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, auf dessen erste Aufforderung hin für auf jede bezogene Packung CYRAMZA einen festgelegten Anteil des Fabrikabgabepreises zurück. Sie gibt dem Krankenversicherer die Höhe der Rückvergütung bekannt. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückvergütung soll ab dem Zeitpunkt der Verabreichung erfolgen.\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 20403.02</div>"},"type":"indication","indication":{"diseaseSymptomProcedure":{"concept":{"text":"In Kombination mit FOLFIRI (Irinotecan, Folsäure und 5-Fluorouracil) zur Behandlung von erwachsenen Patienten mit metastasiertem kolorektalem Karzinom (mKRK) mit Progress während oder nach vorausgegangener Therapie mit Bevacizumab, Oxaliplatin und einem Fluoropyrimidin. Die Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.\nDie Eli Lilly (Suisse) SA vergütet dem Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, auf dessen erste Aufforderung hin für auf jede bezogene Packung CYRAMZA einen festgelegten Anteil des Fabrikabgabepreises zurück. Sie gibt dem Krankenversicherer die Höhe der Rückvergütung bekannt. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückvergütung soll ab dem Zeitpunkt der Verabreichung erfolgen.\nFolgender Indikationscode ist an den Krankenversicherer zu übermitteln: 20403.02"}}}}}]}

data/spec/fhir_spec.rb

@@ -0,0 +1,53 @@
+require "spec_helper"
+require "oddb2xml/downloader"
+require "oddb2xml/extractor"
+require "oddb2xml/fhir_support"
+
+describe "FHIR Indikationscode support" do
+  let(:cyramza_fixture) { File.join(Oddb2xml::SpecData, "fhir", "cyramza.ndjson") }
+
+  describe Oddb2xml::FHIR::ClinicalUseDefinition do
+    it "extracts the .NN suffix from id" do
+      cud = described_class.new("id" => "CYRAMZA.02", "type" => "indication")
+      expect(cud.nn_suffix).to eq("02")
+      expect(cud.indication?).to be true
+    end
+
+    it "returns nil suffix for non-conforming ids" do
+      cud = described_class.new("id" => "CYRAMZA")
+      expect(cud.nn_suffix).to be_nil
+    end
+  end
+
+  describe Oddb2xml::FHIR::Bundle do
+    it "collects ClinicalUseDefinition entries" do
+      line = File.read(cyramza_fixture).lines.first
+      bundle = described_class.new(line)
+      expect(bundle.clinical_use_definitions).not_to be_empty
+      expect(bundle.clinical_use_definitions.map(&:id)).to include("CYRAMZA.01", "CYRAMZA.02")
+    end
+  end
+
+  describe Oddb2xml::FHIR::PreparationsParser do
+    it "constructs XXXXX.NN indication codes from FOPHDossierNumber + CUD suffix" do
+      parser = described_class.new(cyramza_fixture)
+      prep = parser.preparations.first
+      codes = prep.IndicationCodes.map(&:code)
+      expect(codes).to include("20403.01", "20403.02")
+    end
+  end
+
+  describe Oddb2xml::FhirExtractor do
+    it "exposes indication_codes on each item and package" do
+      data = described_class.new(cyramza_fixture).to_hash
+      expect(data).not_to be_empty
+
+      item = data.values.first
+      codes = item[:indication_codes].map { |ic| ic[:code] }
+      expect(codes).to include("20403.01", "20403.02")
+
+      pkg = item[:packages].values.first
+      expect(pkg[:indication_codes]).to eq(item[:indication_codes])
+    end
+  end
+end

metadata

@@ -1,7 +1,7 @@
 --- !ruby/object:Gem::Specification
 name: oddb2xml
 version: !ruby/object:Gem::Version
-  version: 3.0.5
+  version: 3.0.6
 platform: ruby
 authors:
 - Yasuhiro Asaka, Zeno R.R. Davatz, Niklaus Giger
@@ -261,6 +261,20 @@ dependencies:
     - - ">="
       - !ruby/object:Gem::Version
         version: 3.3.9
+- !ruby/object:Gem::Dependency
+  name: csv
+  requirement: !ruby/object:Gem::Requirement
+    requirements:
+    - - ">="
+      - !ruby/object:Gem::Version
+        version: '0'
+  type: :runtime
+  prerelease: false
+  version_requirements: !ruby/object:Gem::Requirement
+    requirements:
+    - - ">="
+      - !ruby/object:Gem::Version
+        version: '0'
 - !ruby/object:Gem::Dependency
   name: standardrb
   requirement: !ruby/object:Gem::Requirement
@@ -512,6 +526,7 @@ files:
 - spec/data/compressor/oddb2xml_files_lppv.txt
 - spec/data/compressor/oddb2xml_files_nonpharma.xls
 - spec/data/epha_interactions.csv
+- spec/data/fhir/cyramza.ndjson
 - spec/data/listen_neu.html
 - spec/data/medregbm_betrieb.txt
 - spec/data/medregbm_person.txt
@@ -539,6 +554,7 @@ files:
 - spec/data_helper.rb
 - spec/downloader_spec.rb
 - spec/extractor_spec.rb
+- spec/fhir_spec.rb
 - spec/fixtures/vcr_cassettes/artikelstamm.json
 - spec/fixtures/vcr_cassettes/oddb2xml.json
 - spec/galenic_spec.rb
@@ -607,6 +623,7 @@ test_files:
 - spec/data/compressor/oddb2xml_files_lppv.txt
 - spec/data/compressor/oddb2xml_files_nonpharma.xls
 - spec/data/epha_interactions.csv
+- spec/data/fhir/cyramza.ndjson
 - spec/data/listen_neu.html
 - spec/data/medregbm_betrieb.txt
 - spec/data/medregbm_person.txt
@@ -634,6 +651,7 @@ test_files:
 - spec/data_helper.rb
 - spec/downloader_spec.rb
 - spec/extractor_spec.rb
+- spec/fhir_spec.rb
 - spec/fixtures/vcr_cassettes/artikelstamm.json
 - spec/fixtures/vcr_cassettes/oddb2xml.json
 - spec/galenic_spec.rb